Newsletter Subject

Infant RSV Vax Heads to FDA for Review

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Tue, Jun 6, 2023 10:53 PM

Email Preheader Text

Daily Headlines Tuesday, June 06, 2023 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIGHT T

[MEDPAGE TODAY]( Daily Headlines Tuesday, June 06, 2023 Today's Top Stories for {NAME} [INFECTIOUS DISEASE]( [Infant RSV Vax Heads to FDA for Review]( [PRACTICE MANAGEMENT]( [Is Getting Test Results Online Right Away a Good Idea? Yes, Patients Say]( [SPECIAL REPORTS]( [Residency Application System Cuts Section on Hobbies and Interests]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Harnessing the Potential of Novel Therapies in Multiple Myeloma]( [PUBLIC HEALTH & POLICY]( [Workplace Harassment, Cyber Incivility High for Minority Groups in Academic Medicine]( [NEUROLOGY]( [Superior Cognition in the Oldest-Old; Novel MS Pathway; What Links Amyloid and Tau?]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [MEETING COVERAGE]( [Phase II Study: Bispecific Oral Drug Tops Leading JAK Inhibitor for RA]( CME SPOTLIGHT [COVID-19 Prevention for Immunocompromised Individuals]( [ENDOCRINOLOGY]( [New Nonhormonal Hot Flash Recs; Global Plastics Treaty; SGLT2 & Lower Cancer Risk?]( [CARDIOLOGY]( [Leaky Impellas Recalled; Andexanet Alfa's Brain Bleed Win; Estrogen Pills & High BP]( [OPINION]( [Schools Aren't Prepared to Treat Asthma Attacks]( CME SPOTLIGHT [Guideline Recommendations for Treatment Selection and Sequencing in Relapsed/Refractory Multiple Myeloma]( [MEETING COVERAGE]( [Closing the Diversity Gaps in Urologic Oncology Leadership]( [MEETING COVERAGE]( [Certain NSCLC Patients May Be Able to Stop Immunotherapy at 2 Years]( [MEETING COVERAGE]( [No Survival Benefit With Immune Checkpoint Inhibitor Rechallenge in Metastatic RCC]( CME SPOTLIGHT [Evidence-Based Strategies for Integrating CAR T-Cell Therapy Into Non-Hodgkin Lymphoma Care]( [MEETING COVERAGE]( [Happy Sleep, Happy Couple?]( [MEETING COVERAGE]( [Once-Nightly Narcolepsy Drug Preferred by Patients Over Twice-Nightly Dose]( [OPINION]( [My Advice to Graduating Medical Students on Using Technology but Staying Human]( CME SPOTLIGHT [Incorporating Recent Data Into Current Treatment Paradigms in Melanoma]( [MEETING COVERAGE]( [The Promising Future of Guselkumab]( [OPINION]( [How I Became a Physician on Food Stamps]( [ASCO READING ROOM]( [Ann Nattinger, MD, MPH, on Shifting Breast Cancer Care to High-Volume Centers]( CME SPOTLIGHT [Expert Perspectives in Managing Lower-Risk Myelodysplastic Syndromes]( [ASCO READING ROOM]( [Well-Conducted Breast Cancer Analysis Quantified Impact of Disparities in Care]( # Weekly Survey [Discipline for Abortion Doc?]( Caitlin Bernard, MD, the Indiana physician who spoke publicly about performing an abortion on a young Ohio rape victim, was [reprimanded and fined]( by Indiana's Medical Licensing Board for allegedly violating patient privacy [VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-06-06&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.